(VIANEWS) – BW LPG (BWLPG.OL), VOSS VEKSEL OGLAND (VVL.OL), DNB BANK (DNB.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. BW LPG (BWLPG.OL)
31.1% sales growth and 20.16% return on equity
BW LPG Limited, an investment holding company, engages in shipowning and chartering activities worldwide. The company operates through Shipping and Product Services segments. It is involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. The company also offers integrated liquified petroleum gas (LPG) delivery services directly to buyers and receivers. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr23.72.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 5.29. Meaning, the purchaser of the share is investing kr5.29 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Yearly Top and Bottom Value
BW LPG’s stock is valued at kr125.40 at 22:20 EST, higher than its 52-week high of kr121.70.
Sales Growth
BW LPG’s sales growth is 20.3% for the ongoing quarter and 31.1% for the next.
More news about BW LPG.
2. VOSS VEKSEL OGLAND (VVL.OL)
16% sales growth and 9.14% return on equity
Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.
Earnings Per Share
As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr26.35.
PE Ratio
VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 8.5. Meaning, the purchaser of the share is investing kr8.5 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.14%.
Yearly Top and Bottom Value
VOSS VEKSEL OGLAND’s stock is valued at kr224.00 at 22:20 EST, way below its 52-week high of kr252.00 and way above its 52-week low of kr190.00.
Volume
Today’s last reported volume for VOSS VEKSEL OGLAND is 128 which is 65.49% below its average volume of 371.
Sales Growth
VOSS VEKSEL OGLAND’s sales growth for the next quarter is 16%.
Moving Average
VOSS VEKSEL OGLAND’s worth is below its 50-day moving average of kr233.96 and above its 200-day moving average of kr221.18.
More news about VOSS VEKSEL OGLAND.
3. DNB BANK (DNB.OL)
12% sales growth and 15.02% return on equity
DNB Bank ASA provides financial services for retail and corporate customers in Norway and internationally. The company offers personal banking products and services, including savings and investment products; loans, such as home mortgages, and car and consumer loans; pet, home and property, travel, and personal insurance products, as well as insurance products for vehicles; retirement savings products; foreign exchange and treasury activities; and Internet and mobile banking services, as well as cards. It also provides business banking products and services comprising savings and investment products consisting of savings accounts, fixed rate deposits, exchange traded products, bonds and commercial papers, asset management, and equity services; financing, such as installment loans, overdraft facility, bank guarantees, leasing, factoring, and trade and export financing services; transaction banking services; research, commodities, bonds and commercial papers, corporate finance, debt capital market, equities, foreign exchange and interest rates, and securities services; and Internet services, including online equity trading, online FX trading, e-confirmation, equities execution, and investor and margin accounts, as well as pension services. In addition, the company provides investment banking services, such as mergers and acquisition, and equity and debt capital market services; foreign exchange, interest rates, equities, commodities, fixed income, research, private equity, and securities services; and corporate banking services. Further, it offers private banking services. The company offers its products and services to various sectors, including energy; financial institutions; healthcare; manufacturing; packaging and forest products; seafood; shipping, offshore, and logistics; and telecom, media, and technology. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, DNB BANK has a trailing twelve months EPS of kr23.24.
PE Ratio
DNB BANK has a trailing twelve months price to earnings ratio of 9.06. Meaning, the purchaser of the share is investing kr9.06 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 74.07B for the twelve trailing months.
More news about DNB BANK.
4. SKUE SPAREBANK (SKUE.OL)
11.9% sales growth and 9.5% return on equity
Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, personal, vehicle, and small loans, as well as mortgage, bank guarantee, overdraft, and leasing services; and home and leisure, car and other vehicles, pet, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.
Earnings Per Share
As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr85.05.
PE Ratio
SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.61. Meaning, the purchaser of the share is investing kr2.61 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.5%.
More news about SKUE SPAREBANK.
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 5.32% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.33.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 67.58. Meaning, the purchaser of the share is investing kr67.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.32%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VISTIN PHARMA’s EBITDA is 2.36.
Moving Average
VISTIN PHARMA’s worth is under its 50-day moving average of kr22.73 and way above its 200-day moving average of kr19.49.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.
More news about VISTIN PHARMA.
